Lexicon drug shows cardiac and platelet effects in preclinical studies

Go back to Lexicon drug shows cardiac and platelet effects in preclinical studies

Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease

October 21, 2026 8:30 AM EDT

-- Preclinical study demonstrates positive effects of sotagliflozin on cardiac function and structure in hypertrophic cardiomyopathy --

-- Second preclinical study shows inhibitory effects of sotagliflozin on platelet activity and thrombus formation --

-- Findings underscore differentiated biology associated with dual SGLT1 and SGLT 2 inhibition --

THE WOODLANDS, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) --... More